Andersen-Tawil syndrome: Difference between revisions

	Andersen-Tawil syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Andersen-Tawil syndrome from other Diseases
Epidemiology and Demographics
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Tertiary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Andersen-Tawil syndrome On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
slides
Images
American Roentgen Ray Society Images of Andersen-Tawil syndrome All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Andersen-Tawil syndrome
CDC on Andersen-Tawil syndrome
Andersen-Tawil syndrome in the news
Blogs on Andersen-Tawil syndrome
Directions to Hospitals Treating Andersen-Tawil syndrome
Risk calculators and risk factors for Andersen-Tawil syndrome

VisualWikitext

Latest revision as of 16:06, 22 September 2021

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

Synonyms and keywords: Andersen syndrome; Andersen cardiodysrhytmic periodic paralysis; long QT syndrome 7; LQT7; periodic paralysis, potassium sensitive cardiodysrhytmic type; hypokalemic periodic paralysis with cardiac arrhythmia

Overview

Historical Perspective

Pathophysiology

Differentiating Andersen-Tawil syndrome from other Diseases

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

Treatment

Case Studies

Case #1

Template:WikiDoc Sources CME Category::Cardiology

@@ Line 1: / Line 1: @@
-{{Infobox_Disease |
+__NOTOC__
-  Name           = {{PAGENAME}} |
+{{Andersen-Tawil syndrome}}
-  Image          = |
+{{CMG}}; {{AE}} {{VKG}}
-  Caption        = |
-  DiseasesDB     = 700 |
-  ICD10          = |
-  ICD9           = {{ICD9|426.82}}, {{ICD9|794.31}} |
-  ICDO           = |
-  OMIM           = 170390 |
-  MedlinePlus    = |
-  eMedicineSubj  = |
-  eMedicineTopic = |
-  MeshID         = D050030 |
-}}
-{{SI}}
-{{WikiDoc Cardiology Network Infobox}}
-{{CMG}}
+{{SK}} Andersen syndrome; Andersen cardiodysrhytmic periodic paralysis; long QT syndrome 7; LQT7; periodic paralysis, potassium sensitive cardiodysrhytmic type; hypokalemic periodic paralysis with cardiac arrhythmia
+==[[Andersen-Tawil syndrome overview|Overview]]==
-'''Andersen-Tawil syndrome''', also called '''Andersen syndrome''' and '''Long QT syndrome 7''', is a form of [[long QT syndrome]]. It is a rare genetic disorder, and is inherited in an [[autosomal dominant]] pattern.
+==[[Andersen-Tawil syndrome historical perspective|Historical Perspective]]==
-==Presentation==
+==[[Andersen-Tawil syndrome pathophysiology|Pathophysiology]]==
-Andersen-Tawil syndrome affects the [[heart]], symptoms are a disruption in the rhythm of the heart's lower chambers (ventricular arrhythmia) in addition to the symptoms of long QT syndrome. There are also physical abnormalities associated with Andersen-Tawil syndrome, these typically affect the head, face, and limbs. These features often include an unusually small lower jaw ([[micrognathia]]), low-set ears, and an abnormal curvature of the fingers called [[clinodactyly]].
-==Type 1 and type 2==
+==[[Andersen-Tawil syndrome differential diagnosis|Differentiating Andersen-Tawil syndrome from other Diseases]]==
-Two types of Andersen-Tawil syndrome are distinguished by their genetic causes.
-* Type 1, which accounts for about 60 percent of all cases of the disorder, is caused by mutations in the ''[[KCNJ2]]'' [[gene]]. <ref>{{cite journal |author=Tristani-Firouzi M, Jensen JL, Donaldson MR, ''et al'' |title=Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome) |journal=J. Clin. Invest. |volume=110 |issue=3 |pages=381-8 |year=2002 |pmid=12163457 |doi=}}</ref><ref>{{cite journal |author=Pegan S, Arrabit C, Slesinger PA, Choe S |title=Andersen's syndrome mutation effects on the structure and assembly of the cytoplasmic domains of Kir2.1 |journal=Biochemistry |volume=45 |issue=28 |pages=8599-606 |year=2006 |pmid=16834334 |doi=10.1021/bi060653d}}</ref>
-* The remaining 40 percent of cases are designated as type 2; the cause of the condition in these cases is unknown.
+==[[Andersen-Tawil syndrome epidemiology and demographics|Epidemiology and Demographics]]==
-The protein made by the ''KCNJ2'' gene forms a [[potassium channel|channel]] that transports potassium ions into [[muscle]] [[cell (biology)|cell]]s. The movement of potassium ions through these channels is critical for maintaining the normal functions of skeletal muscles which are used for movement and cardiac muscle. [[Mutation]]s in the ''KCNJ2'' gene alter the usual structure and function of potassium channels or prevent the channels from being inserted correctly into the cell membrane. Many mutations prevent a molecule called PIP2 from binding to the channels and effectively regulating their activity. These changes disrupt the flow of potassium ions in skeletal and cardiac muscle, leading to the periodic paralysis and irregular heart rhythm characteristic of Andersen-Tawil syndrome.
+==[[Andersen-Tawil syndrome screening|Screening]]==
-Researchers have not yet determined the role of the KCNJ2 gene in bone development, and it is not known how mutations in the gene lead to the developmental abnormalities often found in Andersen-Tawil syndrome.
+==[[Andersen-Tawil syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
-==Eponym==
+==Diagnosis==
-It is named for Ellen Andersen<ref>{{cite journal |author=Andersen ED, Krasilnikoff PA, Overvad H |title=Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome? |journal=Acta paediatrica Scandinavica |volume=60 |issue=5 |pages=559-64 |year=1971 |pmid=4106724 |doi=}}</ref> and R. Tawil.<ref name="pmid8080508">{{cite journal |author=Tawil R, Ptacek LJ, Pavlakis SG, ''et al'' |title=Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features |journal=Ann. Neurol. |volume=35 |issue=3 |pages=326-30 |year=1994 |pmid=8080508 |doi=10.1002/ana.410350313}}</ref><ref>{{WhoNamedIt|synd|3410}}</ref>
+[[Andersen-Tawil syndrome diagnostic criteria|Diagnostic Criteria]] | [[Andersen-Tawil syndrome history and symptoms|History and Symptoms ]] | [[ Andersen-Tawil syndrome physical examination|Physical Examination]] | [[Andersen-Tawil syndrome laboratory findings|Laboratory Findings]] | [[Andersen-Tawil syndrome electrocardiogram|Electrocardiogram]] |[[Andersen-Tawil syndrome chest x ray|Chest X Ray]] | [[Andersen-Tawil syndrome CT|CT]] | [[Andersen-Tawil syndrome MRI|MRI]] | [[Andersen-Tawil syndrome echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Andersen-Tawil syndrome other imaging findings|Other Imaging Findings]] | [[Andersen-Tawil syndrome other diagnostic studies|Other Diagnostic Studies]]
-==References==
+==Treatment==
-<references/>
+[[Andersen-Tawil syndrome medical therapy|Medical Therapy]] | [[Andersen-Tawil syndrome surgery |Surgery]] | [[Andersen-Tawil syndrome primary prevention|Primary Prevention]] | [[Andersen-Tawil syndrome secondary prevention|Secondary Prevention]] | [[Andersen-Tawil syndrome tertiary prevention|Tertiary Prevention]] | [[Andersen-Tawil syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Andersen-Tawil syndrome future or investigational therapies|Future or Investigational Therapies]]
-==Source==
+==Case Studies==
+[[Andersen-Tawil syndrome case study one|Case #1]]
-* ''This article incorporates public domain text from [http://ghr.nlm.nih.gov The U.S. National Library of Medicine]''
 {{Electrocardiography}}
 {{Circulatory system pathology}}
+{{WikiDoc Help Menu}}
+{{WikiDoc Sources}}
+[[CME Category::Cardiology]]
 [[Category:Electrophysiology]]
-[[Category:Channelopathy|Andersen-Tawil syndrome]]
+[[Category:Disease]]
 [[Category:Genetic disorders]]
 [[Category:Cardiology]]
-{{WikiDoc Help Menu}}
-{{WikiDoc Sources}}

v t e Electrocardiography
Overview	History of the EKG • EKG interpretation basics • Normal sinus rhythm
EKG Complexes	P wave • QRS complex • ST Segment • T wave • T wave alternans • Tombstone T wave • U wave Osborn wave • H wave • K wave • Delta wave NSSTW changes
EKG Intervals	PR Interval • QRS Interval • ST Interval • QT Interval
Conduction System & Bradycardia	Cardiac pacemaker • SA node • AV node• Bundle of His • Purkinje fibers • Sinus bradycardia • First Degree AV Block • Second Degree AV Block • Complete or Third-Degree AV Block • Concealed conduction • AV Junctional Rhythms • LBBB • LAHB • LPHB • RBBB • Trifascicular block
Atrial Arrhythmias	Sinus tachycardia • Premature Atrial Contractions (PACs) • Ectopic Atrial Rhythm • Paroxysmal Atrial Tachycardia (PAT) • Paroxysmal Atrial Tachycardia (PAT) with Block • Multifocal Atrial Tachycardia (MAT) • Atrial Flutter • Atrial Fibrillation • Wandering atrial pacemaker
Ventricular Arrhythmias	Differential Diagnosis of Tachycardia with a Wide QRS Complex • Accelerated Idioventricular Rhythm • Ventricular Parasystole • Premature Ventricular Contractions (PVCs) • Ventricular tachycardia • Ventricular Fibrillation • Sudden cardiac death
EKG Abnormalities in Disease States	Hypertrophy & Dilatation • Right atrial enlargement • Left atrial enlargement • Biatrial enlargement • Left Ventricular Hypertrophy • Right Ventricular Hypertrophy • Biventricular Hypertrophy • Acute myocardial infarction • NSTEMI • STEMI • Tombstone ST elevation • Right ventricular myocardial infarction • Atrial infarction Pre-excitation Syndromes • Wolff-Parkinson-White Syndrome • Lown Ganong Levine Syndrome • Mahaim Type Preexcitation Cardiomyopathies • Arrhythmogenic Right Ventricular Dysplasia • Dilated Cardiomyopathy • Hypertrophic Cardiomyopathy Drug Effects on the EKG • Adenosine • β-blockers • Digitalis • Quinidine • Procainamide • Disopyramide • Lidocaine • Tocainide and Mexiletine • Phenytoin • Encainide, Flecainide and Propafenone • Amiodarone • Bretylium • Ca Channel Blockers • Phenothiazines • Tricyclic Antidepressants • Lithium Congenital Heart Disease • Dextrocardia • Atrial Septal Defect • Ventricular Septal Defect • Tetralogy of Fallot • Conjoined Twins or Siamese Twins • Congenital heart block Electrolyte Disturbances • Hyperkalemia • Hypokalemia • Hypercalcemia • Hypocalcemia • Nonspecific Changes Other Heart Diseases • Pericarditis • Myocarditis • Tamponade • Heart Transplantation • Sick Sinus Syndrome • Long QT Syndrome Inherited Disease • Brugada Syndrome Systemic Diseases • CNS Disease • Cardiac Tumors Heart Transplantation • EKG Changes in patient with Heart Transplantation Exogenous Effects • Hypothermia • Chest Trauma • Insect Bites • Electric Injuries
Technical Issues and Potential Errors in Interpretation	Artifacts • Lead Placement Errors • The EKG in a Patient with a Pacemaker • EKG in athletes